What are the recommended non‑pharmacologic and pharmacologic treatments for agitation in a pregnant patient?

Treatment of Agitation During Pregnancy

For agitation in pregnancy, begin with verbal de-escalation immediately, and if pharmacologic intervention is required, use intramuscular promethazine 25 mg for mild-to-moderate agitation or intramuscular haloperidol 1.25-5 mg for moderate-to-severe agitation, as these agents have the most favorable safety profiles and clinical evidence in pregnant patients. 1, 2

Critical Context: This is an Obstetric Emergency

Agitation during pregnancy must be treated as an obstetric emergency because maternal distress directly jeopardizes both the patient and fetus 1, 3. Delayed or inadequate treatment poses greater risk than judicious use of appropriate medications.

Algorithmic Approach to Management

Step 1: Rapid Medical Evaluation (Concurrent with Management)

While controlling agitation, immediately assess for dangerous medical etiologies:

• Point-of-care glucose testing (mandatory for all patients)
• Vital signs including temperature
• Signs of infection, metabolic derangement, or toxidromes
• Neurologic examination for focal deficits
• Substance use history (particularly stimulants, which are increasingly common in pregnancy) 4

Step 2: Non-Pharmacologic Intervention (First-Line)

Verbal de-escalation should always be attempted first 1, 3, 5:

• Move patient to quiet, low-stimulation environment
• Use calm, non-threatening communication
• Maintain safe distance and body positioning
• Offer choices when possible to restore sense of control

In one tertiary care study, verbal de-escalation alone was effective in 3.95% of agitated pregnant patients, avoiding medication entirely 2.

Step 3: Pharmacologic Management (When Non-Pharmacologic Fails)

The medication choice depends on agitation severity:

For Mild-to-Moderate Agitation:

• Diphenhydramine or Promethazine (preferred first-line)
  • Promethazine 25 mg IM was the most commonly used agent (32.20% of cases) in a large tertiary care analysis 2
  • Diphenhydramine is effective with minimal adverse fetal effects 1
  • These antihistamines provide sedation without hemodynamic instability

For Moderate-to-Severe Agitation:

• Haloperidol (first-generation antipsychotic - preferred)
  • Haloperidol 1.25 mg IM (second most common treatment at 14.69%) 2
  • Can escalate to 2.5-5 mg IM if needed
  • High-potency typical antipsychotics are preferred due to neutral hemodynamic effects 1
  • Haloperidol has become the most frequently utilized antipsychotic for agitation during pregnancy 1
  • May combine with promethazine 25 mg (used in 6.78% of cases) 2

Second-Line Options:

• Second-generation antipsychotics (if first-generation fails)
  • Olanzapine 5 mg PO (used in 10.17% of cases) 2
  • Risperidone (mentioned as second-line option) 1
  • Quetiapine 50 mg (used sparingly, 1.13% of cases) 2

Use With Extreme Caution (Higher Risk):

• Benzodiazepines - should be used sparingly

  • Lorazepam 2 mg (PO/IM/IV) was used in only 14.68% combined 2
  • Benzodiazepines have demonstrated adverse fetal outcomes 1
  • Reserve for cases where antipsychotics are contraindicated or ineffective

• Ketamine - avoid if possible

  • Has demonstrated adverse fetal outcomes 1

Step 4: Physical Restraints (Last Resort Only)

Physical restraints should be reserved as the absolute last option when patient poses imminent danger and all other interventions have failed 5. In the tertiary care study, none of the pregnant patients required physical restraints 2, suggesting that appropriate pharmacologic management can nearly always avoid this intervention.

Key Dosing Principles

Always use the lowest effective dose - the fetal risk of multiple or high doses of psychotropic medications remains unknown 1. The tertiary care data shows successful management with:

• Low-dose haloperidol (1.25-2.5 mg, not the typical 5-10 mg used in non-pregnant patients)
• Single doses of promethazine (25 mg)
• Conservative benzodiazepine dosing when necessary (2 mg lorazepam)

Critical Pitfalls to Avoid

1. Delaying treatment due to pregnancy concerns - untreated agitation poses greater risk than appropriate medication use 1, 3

2. Using benzodiazepines as first-line - despite their common use in non-pregnant patients, they have worse fetal outcomes than antipsychotics in pregnancy 1

3. Failing to assess for stimulant use - stimulant use disorder in pregnancy is increasingly common and requires specific management considerations 4

4. Using typical non-pregnant doses - pregnant patients often respond to lower doses, reducing fetal exposure 2

5. Not consulting obstetrics early - early consultation allows for fetal monitoring and coordinated care 3

Consultation Strategy

• Obstetrics consultation: Immediate for fetal monitoring and coordinated care
• Psychiatry consultation: For ongoing management, especially if substance-induced psychosis or underlying psychiatric disorder 4
• Both services should be involved early in the clinical course 3